Keywords: xeloda, better, colon, cancer, gold-standard, pre-planned, multivariate

Xeloda better than colon cancer gold-standard

Article | 07 July 2008

A pre-planned multivariate analysis of the five-year follow-up data from the X-ACT study shows that patients receiving chemotherapy after-surgery to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

capecitabine

Xeloda

Go to drug listing